Mayd runs an app-based platform for fast delivery of pharmacy products and non-prescription medicines, promising deliveries within 30 minutes between 8am and midnight. The service currently offers access to 2,000+ prescription-free medicines and has expanded from Berlin into Hamburg, Munich, Frankfurt am Main, Cologne and Düsseldorf, with Stuttgart launching soon. It employs 100+ staff and 350+ delivery riders who are directly contracted rather than subcontracted. Mayd is preparing for upcoming e-prescription changes in Germany that will allow it to accept prescription orders and says it will charge pharmacies a platform fee for e-prescriptions while keeping consumer-facing e-prescription delivery free. Typical customers skew female, aged about 35–45, are urban and convenience-focused; the company reports larger basket sizes than online grocery orders. The business plans to use new funding to hire in technology, ramp operations, and expand further in Germany and into additional European markets. Mayd partners with small-scale pharmacies to provide on-demand delivery of medicines and pharmacy items, promising deliveries within 30 minutes for orders placed before midnight. The company launched at the beginning of this year and is starting operations in Berlin, where it has around 30 pharmacy partners covering most of the city. Riders are full-time employees (not gig workers) and the service initially offers non-prescription products; prescription fulfillment will begin once Germany’s e-prescription reimbursement goes live in January. Mayd integrates with pharmacy infrastructure (including QR-code workflows) and enforces pharmacist control over deliveries and patient advice before prescription delivery. The business model takes a commission on non-prescription sales and charges a delivery or listing fee for e-prescription deliveries. It raised €13 million ($15 million) in seed funding to build out logistics, regulatory integrations, and recruitment, and plans to expand to other German cities this year with eventual wider European expansion, citing a €60 billion addressable market in Germany.

Total raised

$49M

Funding rounds

2

Latest round

Series A

Latest activity

Jan 2022